- Heavy caseloads for MS specialist nurses
- Ocrevus slows progression in upper limbs
- Parenting with MS
- Trains and planes and disability
- Vitamin D recommendation
The MS Trust is delighted to announce that South Tees, NHS Lothian, Hull and North Lincs and Goole will be the next areas to benefit from our pioneering Specialist Nurse Programme.
The Scottish Medicines Consortium (SMC) has decided that fampridine (Fampyra) will not be made available on the NHS in Scotland for people with MS-related walking problems.
- The effect of pregnancy on MS
- Ocrevus for PPMS decision paused
- Coexisting conditions affect atrophy
- Medical cannabis rule change in Jersey
Radio 1 DJ Scott Mills, whose mum has MS, recently presented our BBC Lifeline Appeal. Here he tells us how his family have adapted to his mum’s MS diagnosis, the importance of speaking out about MS, and why his mum is his biggest inspiration.
A new report published this week by the MS Trust finds that many MS specialist nurses are routinely managing more patients than the recommended caseload. As a result, people with MS are missing out on the vital care and support they need and deserve.
From 1 November, specialist clinicains will be able to legally prescribe cannabis-derived medicinal products to patients with exceptional clinical need.
NICE has announced that it is pausing the publication of final guidance on ocrelizumab for PPMS while further discussions take place between drug company and NHS England.
- MS-SMART trail unsuccessful
- People with progressive MS need early support
- PIP rules protest
- Is cannabis effective?
- The role of vitamin D unclear
- Pregabalin and gabapentin restrictions
- Statue by sculptor with MS unveiled
- More MS risk genes identified
- Gut enzyme potentially linked to MS